Overview

Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension

Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and efficacy of bimatoprost in patients with glaucoma or ocular hypertension
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Allergan
Treatments:
Bimatoprost